CID 3033963

Rocepafant

Structural Information

Molecular Formula
C26H23ClN6OS2
SMILES
CC1=NN=C2N1C3=C(C4=C(S3)CN(CC4)C(=S)NC5=CC=C(C=C5)OC)C(=NC2)C6=CC=CC=C6Cl
InChI
InChI=1S/C26H23ClN6OS2/c1-15-30-31-22-13-28-24(18-5-3-4-6-20(18)27)23-19-11-12-32(14-21(19)36-25(23)33(15)22)26(35)29-16-7-9-17(34-2)10-8-16/h3-10H,11-14H2,1-2H3,(H,29,35)
InChIKey
WBGAFGNZNGJVNW-UHFFFAOYSA-N
Compound name
9-(2-chlorophenyl)-N-(4-methoxyphenyl)-3-methyl-17-thia-2,4,5,8,14-pentazatetracyclo[8.7.0.02,6.011,16]heptadeca-1(10),3,5,8,11(16)-pentaene-14-carbothioamide
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

51
References

128
Patents

534.1063 Da
Monoisotopic Mass

4.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 535.11358 223.1
[M+Na]+ 557.09552 237.1
[M+NH4]+ 552.14012 230.1
[M+K]+ 573.06946 228.7
[M-H]- 533.09902 228.5
[M+Na-2H]- 555.08097 228.3
[M]+ 534.10575 227.9
[M]- 534.10685 227.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe